New research from the University of Georgia suggests that something as simple as a cup of tea can help in the fight against COVID-19.
Apr 8, 2024
0
639
Pulmonary diseases are a leading cause of morbidity and mortality worldwide. For many progressive lung diseases like idiopathic pulmonary fibrosis (IPF), a key issue is a low supply of new stem cells to repair and reverse ...
Apr 10, 2024
0
136
A new, Yale-led study suggests that a range of respiratory viral infections—including COVID-19 and influenza—may be preventable or treatable with a generic antibiotic that is delivered to the nasal passageway.
Apr 22, 2024
0
98
Half of all patients discharged from hospital after a heart attack are treated with beta-blockers unnecessarily. This is according to a new study published in the New England Journal of Medicine.
Apr 8, 2024
0
69
Every now and then, scientists develop treatments that end up being even more popular for another condition entirely. Think of Viagra, originally for high blood pressure, now used for erectile dysfunction. Or thalidomide, ...
Apr 2, 2024
0
0
A University of Oklahoma study about a "black box warning" for the asthma drug Singulair continues to influence a national conversation about the medication and its reported neuropsychiatric side effects in children and adolescents. ...
Apr 5, 2024
0
24
Researchers with McMaster University have found that a commonly prescribed dementia medication doesn't increase the risk of death or certain heart rhythm problems, contrary to past warnings.
Apr 15, 2024
0
12
In recent years, cancer immunotherapy, exemplified by PD-1 and its ligand PD-L1 blockade, has made remarkable advances. But while immunotherapy drugs offer new treatment possibilities, only about 20% to 40% of patients respond ...
Apr 11, 2024
0
1
Prasinezumab, a monoclonal antibody, is shown to reduce signs of motor deterioration in individuals with Parkinson's disease (PD) who have rapidly progressing disease, as reported in an exploratory analysis of data from a ...
Apr 16, 2024
0
111
In recent years, the popularity of drugs like Ozempic and Wegovy has skyrocketed. While this new class of drugs, called GLP-1 receptor agonist drugs, are approved for use in diabetes and for weight loss, researchers have ...
Apr 11, 2024
0
21
